Cerebral Palsy - Quest Diagnostics Patient Health Library Cerebral Palsy Medications Medications can help control some of the symptoms of cerebral palsy (CP), prevent or minimize complications , and treat other medical conditions related to CP.
Anticonvulsants for cancer pain - [Medication] - Quest Diagnostics Patient Health Library Anticonvulsants for cancer pain Examples Brand Name Chemical Name Tegretol carbamazepine Neurontin gabapentin Keppra levetiracetam Trileptal oxcarbazepine Dilantin phenytoin Topamax topiramate Zonegran zonisamide How It Works Anticonvulsants control cancer pain by altering the way sodium and calcium travel across the surface of nerve cells in the brain.
Zonisamide for epilepsy - [Medication] - Quest Diagnostics Patient Health Library Zonisamide for epilepsy Examples Brand Name Chemical Name Zonegran zonisamide Zonisamide requires several daily doses and comes in capsule form.Zonisamide has been approved for treatment of partial seizures in people older than 16.
BioPortfolio Limited Treatment of Epilepsy 5.1 Monotherapy is the Preferable Treatment for Epilepsy 5.2 Monotherapies Do Not Dominate the Anticonvulsant Market 5.3 Brand Name Medications are Important for Epilepsy Sufferers 5.4 Anticonvulsants Can Be Divided into Two Groups: First- and Second-Generation 5.5 First-Generation Anticonvulsants 5.5.1 Carbamazepine (Tegretol/Carbatrol) 5.5.2 Valproate ...
http://www.fda.gov/cder/orange/appendix_a.txt 4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
Prescription and Over-the-Counter Drug Product List: 8/2003 4MG/HR N74607 001 AUG 30, 1996 AUG CRLD >A> AB2 + 0.4MG/HR N74607 001 AUG 30, 1996 AUG CRLD >D> AB2 0.6MG/HR N74559 001 AUG 30, 1996 AUG CRLD >A> AB2 + 0.6MG/HR N74559 001 AUG 30, 1996 AUG CRLD >D> TRANSDERM-NITRO >D> AB2 + NOVARTIS 0.1MG/HR N20144 001 FEB 27, 1996 AUG DISC >A> @ 0.1MG/HR N20144 001 FEB 27, 1996 AUG DISC >D> AB2 + 0.2MG/HR N20144 002 FEB 27, 1996 AUG DISC >A> @ 0.2MG...
author: AUTHOR
Report to the Nation: Drug Review Priority new drug approvals (N=NME) Abacavir/lamivudine/zidovudine (Trizivir) Alosetron (Lotronex) (N) Arsenic trioxide (Trisenox) (N) Atovaquone/proquanil (Malarone) Bexarotene (Targetin) Budesonide (Pulmicort) Didanosine (Videx EC) Gentuzumab ozogamicin (Mylotarg) (N) Levobetaxolol (Betaxon) Levofloxacin (Quixin) Linezolid (Zyvox) (3 NDAs approved, 1 as NME) (N) Lopinavir/ritonavir...
author: OLIVERN
NMEs Approved in CY 2000 NMEs Approved in Calendar Year 2000 NDA Number Generic Name- Trade Name Dosage Form Applicant - --- Classification- Approval Date 20-989 Cevimeline HCl Evoxac Capsule Snowbrand 1S 01-11-2000 21-014 Oxcarbazepine Trileptal Tablet Novartis Pharms 1S 01-14-2000 20-987 Pantoprazole Sodium Protonix Tablet Wyeth Ayerst 1S 02-02-2000 21-107 Alosetron HC1 Lotronex Tablet Glaxo Wellcome 1P 02...
author: Susan Daugherty
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products - ZONEGRAN has multiple mechanisms involved in neuronal modulation *†‡ 12 - 21 Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Click image to enlarge †Not all mechanisms involved in epileptogenesis are known
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products - The convenience of once-daily dosing Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Offers greater ease of use Promotes high compliance rates 11 Patients can dose at bedtime and still be covered the next day Click image to enlarge ...
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products - ZONEGRAN is the only once-daily AED with a 63-hour half-life Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Click image to enlarge Longer half-life assures consistent therapeutic levels Low therapeutic levels of AEDs are a major...
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products - ZONEGRAN is well tolerated Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Click image to enlarge ZONEGRAN is indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsyZonisamide is...
Microsoft Word - apltr.doc Zonisamide is a white powder, pKa = 10.2, and is moderately soluble in water (0.80 mg/ mL) and 0.1 N HCl (0.50 mg/ mL)Zonisamide demonstrated anticonvulsant activity in several experimental modelsZonisamide also has weak carbonic NDA 20- 789/ S- 001; Zonegran (zonisamide) Capsules 25, 50, 100 mg FDA Approved Labeling Text – August 22, 2003 2...
author: WAREJ
Microsoft Word - apltr.doc page 3
author: WAREJ
Microsoft Word - apltr.doc page 2
author: WAREJ
Microsoft Word - apltr.doc page 1
author: WAREJ
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products - ZONEGRAN provides clinically proven efficacy from the start Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Click image to enlarge ZONEGRAN is effective at ranges of 100 to 600mg/day * * Clinical trials suggest no increased...
ZONEGRAN ZONEGRAN ® (zonisamide) --|- Elan Products ZONEGRAN offers efficacy with these confidence-building benefits Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Click image to enlarge ZONEGRAN is indicated as adjunctive therapy in the treatment of partial seizures in adults...
ZONEGRAN ZONEGRAN® (zonisamide) --|- Elan Products - ZONEGRAN offers efficacy with these confidence-building benefits Benefits Safety Half-life Dosing Mechanism of Action Efficacy Prescribing Information References Few drug-to-drug interactions Minimal cognitive impairment 63-hour half-life — the longest of any newer AED Convenient QD...
Report.PDF page 10
author: default
0403-4.0.qxd page 9
author: BessingerB
Document Information Page Zonisamide is a white powder, pKa = 10.2, and is moderately soluble in water (0.80 mg/ mL) and 0.1 N HCl (0.50 mg/ mL)Zonisamide extensively binds to erythrocytes, resulting in an eight- fold higher concentration of zonisamide in red blood cells (RBC) than in plasmaZonisamide with Other Antiepilepsy Drugs (AEDs): Concurrent medication with...
author: FDA.USER
Document Information Page page 20
author: FDA.USER
Document Information Page page 13
author: FDA.USER
Document Information Page page 12
author: FDA.USER
